Skip to main content
Loading ResearchHub…
Cited by — Sunitinib in Patients With Various Solid Tumors With FGFR1 / 2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study | ResearchHub - ResearchHub